Nobody would argue that the 2005 decision extending the committee's legislative powers to include the National Immunisation Program has made it easier for vaccine makers. If you give them more powers, they will use them to impose more hurdles and test the limits, including with their minister.
Who are 'legislated conditional listings' designed to limit, the industry or the minister?
May 11, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
The private market might do what two decades of PBS reform attempts couldn't
October 12, 2026 - - Latest News -
The full set of numbers tell the story and reveal the massive funding shortfall
October 12, 2026 - - Latest News -
Private prescription market heads towards $4 billion as PBS spending stalls
October 12, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
October 9, 2026 - - Podcast -
PhRMA goes to court over price rule that uses Australia as a benchmark
October 9, 2026 - - Latest News -
A tale of two systems with billions shifting to the private market
October 9, 2026 - - Latest News -
GLP-1s are quickly reshaping the Australian prescription medicines market
October 9, 2026 - - Latest News
